©The Author(s) 2019.
World J Gastrointest Pharmacol Ther. Jan 21, 2019; 10(1): 29-34
Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.29
Published online Jan 21, 2019. doi: 10.4292/wjgpt.v10.i1.29
Table 1 Labs at admission
| Items | Data |
| WBC | 20.39 × 109/L |
| Neutrophil | 61% |
| Lymphocytes | 6% |
| Monocytes | 6% |
| Eosinophil | 0% |
| Hemoglobin | 9.9 mmol/L |
| Platelets | 335 × 109/L |
| RDW | 20% |
| Sodium | 132 mmol/L |
| Potassium | 2.8 mmol/L |
| Chloride | 92 mmol/L |
| CO2 | 7 mmol/L |
| Creatinine | 486.2 µmol/L |
| Calcium | 2.3 mmol/L |
| Anion gap | 33 mmol/L |
| Albumin | 0.57 mmol/L |
| Phosphorous | 3 mmol/L |
| AST | 15 IU/L |
| ALT | 26 IU/L |
| Total bilirubin | 6.8 µmol/L |
| Alkaline phosphatase | 110 IU/L |
| Magnesium | 1.1 mmol/L |
- Citation: Nassri AB, Muenyi V, AlKhasawneh A, Ribeiro BDS, Scolapio JS, Malespin M, de Melo Jr SW. Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report. World J Gastrointest Pharmacol Ther 2019; 10(1): 29-34
- URL: https://www.wjgnet.com/2150-5349/full/v10/i1/29.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v10.i1.29